Patents by Inventor Arend Jan Winter

Arend Jan Winter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric adenoviral vectors
    Patent number: 6479290
    Abstract: The invention concerns adenoviral vectors having the characteristic of containing a region essential for heterologous packaging with respect to the adenoviral genome from which they are derived. The invention also concern a method for making a viral preparation containing said adenoviral vectors, a cell, a pharmaceutical composition or material comprising them and their therapeutic or prophylactic use. Finally, the invention concerns an adenoviral genome of animal origin having attenuated packaging properties with respect tot he native genome from which it is derived.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: November 12, 2002
    Assignee: Transgene S. A.
    Inventors: Majid Mehtali, Monika Lusky, Arend Jan Winter
  • Chimeric adenoviral vectors
    Publication number: 20020019051
    Abstract: The invention concerns adenoviral vectors having the characteristic of containing a region essential for heterologous packaging with respect to the adenoviral genome from which they are derived. The invention also concerns a method for making a viral preparation containing said adenoviral vectors, a cell, a pharmaceutical composition or material comprising them and their therapeutic or prophylactic use. Finally, the invention concerns an adenoviral genome of animal origin having attenuated packaging properties with respect to the native genome from which it is derived.
    Type: Application
    Filed: May 31, 2001
    Publication date: February 14, 2002
    Inventors: Monika Lusky, Arend Jan Winter
  • Expression of a foamy virus envelope protein
    Patent number: 6277601
    Abstract: The invention concerns constructs for the expression of a protein comprising at least a modified FV envelope protein, the protein so obtained as well as the complementation cell line permitting the production of pseudotyped viral particle. It also concerns pharmaceutical composition comprising said particles and a method for treating a disease.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: August 21, 2001
    Assignee: Transgene S.A.
    Inventors: Axel Rethwilm, Dirk Lindemann, Arend Jan Winter
  • Expression of a foamy virus envelope protein
    Patent number: 6111087
    Abstract: The invention concerns constructs for the expression of a protein comprising at least a modified FV envelope protein, the protein so obtained as well as the complementation cell line permitting the production of pseudotyped viral particle. It also concerns pharmaceutical composition comprising said particles and a method for treating a disease.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: August 29, 2000
    Assignee: Transgene S.A.
    Inventors: Axel Rethwilm, Dirk Lindemann, Arend Jan Winter